Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vertex Pharmaceuticals

Vertex Raises 2022 Outlook As Powerhouse Trikafta Drives Quarterly Beat

Vertex Pharmaceuticals said its triple-regimen in cystic fibrosis is gaining new users abroad. VRTX stock jumped Friday.

Investors Business Daily

Dow Jones Falls After Jobless Data; Alibaba Jumps On Earnings

Dow Jones Falls After Jobless Data; Alibaba Jumps On Earnings

The Dow Jones Industrial Average fell Thursday after jobless claims data. Next, investors await Friday's highly anticipated jobs report.

Investors Business Daily

Dow Jones Rallies Amid Key Economic Data; AMD Tumbles On Weak Sales Outlook

Dow Jones Rallies Amid Key Economic Data; AMD Tumbles On Weak Sales Outlook

The Dow Jones Industrial Average climbed Wednesday ahead of new economic data, while AMD stock dived 6% on a weak sales outlook.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Dow Jones Sells Off As Pelosi Heads To Taiwan; Uber Surges On Strong Sales

Dow Jones futures dropped 200 points Tuesday on rising U.S.-China tensions, as House Speaker Nancy Pelosi heads to Taiwan.

Investors Business Daily

Dow Jones Futures Fall: 7 Top Stocks To Buy And Watch In Today's Stock Market

Dow Jones futures fell 130 points early Tuesday. Seven stocks to buy and watch include energy giants Chevron and Exxon.

Investors Business Daily

Dow Jones Falls As Boeing Surges; Chinese EV Stocks Rise On Deliveries

The Dow Jones Industrial Average fell 150 points Monday, as Boeing surged on 787 Dreamliner news. Chinese EV stocks rose on July deliveries.

Investors Business Daily

Dow Jones Reverses Higher Despite Hot Inflation Report; Amazon, Apple Rally On Earnings

The Dow Jones Industrial Average reversed higher Friday on a hot inflation report. Amazon and Apple rallied on strong results.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Rises As GDP Signals Recession; Meta Slides On Earnings; Apple Earnings Due

Dow Jones Rises As GDP Signals Recession; Meta Slides On Earnings; Apple Earnings Due

The Dow Jones Industrial Average rose Thursday, as tech giant Meta Platforms slid on weak earnings results. Apple earnings are due next.

Investors Business Daily

Dow Jones Rises Ahead Of Fed Decision; Alphabet, Microsoft Earnings Miss

Dow Jones Rises Ahead Of Fed Decision; Alphabet, Microsoft Earnings Miss

The Dow Jones Industrial Average rallied 130 points Wednesday ahead of the Federal Reserve's interest-rate decision.

Investors Business Daily

Dow Jones Falls As Walmart Plunges On Profit Warning; Alphabet, Microsoft Earnings Due

Dow Jones Falls As Walmart Plunges On Profit Warning; Alphabet, Microsoft Earnings Due

The Dow Jones Industrial Average fell Tuesday, as Walmart plunged on a profit warning. Alphabet and Microsoft earnings are due late.

Investors Business Daily

Dow Jones Futures Fall As Walmart Dives On Profit Guidance Cut; What To Do Ahead Of Fed Decision

Dow Jones Futures Fall As Walmart Dives On Profit Guidance Cut; What To Do Ahead Of Fed Decision

Dow Jones futures fell 150 points ahead of Wednesday's Fed decision. Walmart dived Tuesday after lowering its profit guidance.

Investors Business Daily

Why Top-Notch Biotech Stock Vertex Pharmaceuticals Just Hit A Record

Why Top-Notch Biotech Stock Vertex Pharmaceuticals Just Hit A Record

The FDA cleared Vertex to restart testing a diabetes treatment, and VRTX stock jumped to a fresh high Wednesday.

Investors Business Daily

Analyzing Vertex Pharmaceuticals's Short Interest

Analyzing Vertex Pharmaceuticals's Short Interest

Vertex Pharmaceuticals's (NASDAQ:VRTX) short percent of float has fallen 11.26% since its last report. The company recently reported that it has 3.42 million shares sold short, which is 1.34% of all regular shares that are available for trading.

VRTX is the Growth Stock of the Week

VRTX is the Growth Stock of the Week

The market is in a tough place with stubbornly high inflation, a hawkish Fed, and a slowing economy. These conditions are tough for most stocks, but pharmaceuticals are an exception. One of the top companies in the space is Vertex Pharmaceuticals (VRTX). Read on to find out why it's our…

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Biotech Stock United Therapeutics Revives Breakout, Retakes Buy Zone

Biotech stock United Therapeutics joins peers Vertex and Harmony Biosciences on the Breakout Stocks Index as it reenters a buy zone.

$100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth This Much Today

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 8.19% on an annualized basis producing an average annual return of 15.06%. Currently, Vertex Pharmaceuticals has a market capitalization of $67.67 billion.

Expert Ratings for Vertex Pharmaceuticals

Over the past 3 months, 8 analysts have published their opinion on Vertex Pharmaceuticals (NASDAQ:VRTX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Investors Business Daily

Dow Jones Dives On Hot Inflation Report; DocuSign Plunges 23% On Earnings

The Dow Jones Industrial Average dived Friday on a hot inflation report in the wake of Thursday's stock market sell-off. DocuSign plunged on earnings.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Falls As Jobless Claims Jump; Tesla Rallies On China Sales

The Dow Jones Industrial Average fell Thursday after unemployment data. Tesla stock raced higher on news that May sales in China rebounded.

Vertex Pharma Gains FDA Breakthrough Therapy Designation For Kidney Disease Drug

Vertex Pharmaceuticals (NASDAQ: VRTX) received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for its drug candidate inaxaplin (VX-147) for the treatment of patients with APOL1-mediated focal segmental glomerulosclerosis (FSGS).

Investors Business Daily

Dow Jones Falls As Treasury Yields Climb; Tesla Races Higher On Battery Deal

The Dow Jones Industrial Average fell Wednesday, as Treasury yields jumped. Top stocks to buy and watch include cosmetics leader Ulta Beauty.

Investors Business Daily

Dow Jones Futures Fall After Bullish Market Action; Tesla To Buy Batteries From Top EV Rival

The market rally had a bullish reaction to the new Target warning. China EV giant BYD will supply batteries to Tesla.

Investors Business Daily

IBD Stock Of The Day: Vertex Briefly Breaks Out On Bullish Diabetes Data

Recent IBD Stock Of The Day Vertex Pharmaceuticals briefly broke out Wednesday on promising test results in diabetes.

Investors Business Daily

Dow Jones Slides As Target Dives On Profit Warning; Tesla Skids

The Dow Jones Industrial Average sold off Tuesday, as Target dived after warning profits would drop in the current quarter.

Investors Business Daily

Dow Jones Futures: Treasury Yields Jump; 7 Top Stocks To Buy And Watch Now

Dow Jones futures were lower after Monday's stock market action. The 10-year Treasury yield jumped back above 3%.

People

Jaimini DesaiJaimini

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Intel Corporation

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

266,692 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play